Over the past sixteen months, Chinese-domiciled biotechnology companies have solidified their position as pivotal players in the global pharmaceutical landscape,…
Read More

Over the past sixteen months, Chinese-domiciled biotechnology companies have solidified their position as pivotal players in the global pharmaceutical landscape,…
Read More
Madrigal Pharmaceuticals has significantly bolstered its pipeline for metabolic dysfunction-associated steatohepatitis (MASH) by acquiring the global rights to Arrowhead Pharmaceuticals’…
Read More
In an era defined by the dual crises of mounting environmental degradation and an urgent need for sustainable energy, a…
Read More
As World Immunization Week recently concluded, underscoring the vital importance of vaccination in public health, the scientific community is now…
Read More
In a significant move poised to democratize access to high-demand technological education, Zero To Mastery (ZTM), a leading online learning…
Read More
In a stark assessment of the current public health landscape, Dr. Daniel Griffin and Vincent Racaniello, in their weekly clinical…
Read More
Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…
Read More
The global race to secure a steady supply of critical minerals has taken an unexpected turn following a groundbreaking discovery…
Read More
A collaborative research initiative led by the University of the Witwatersrand (Wits) in South Africa and Huzhou University in China…
Read More
Off the northwestern coast of mainland Europe, an island nation with significant ambitions for its life sciences sector is navigating…
Read More